ZeCardio Therapeutics (ZeCardioTx), a Barcelona based pharma company focused on the discovery of cardiovascular drugs using the zebrafish model and an innovative, proprietary screening and analysis platform, ZeCardio®, selected Taros Chemicals’ SVP Drug Discovery, Dr. Torsten Hoffmann, to join the…
Communication is key to success, this is also true for science
Stay updated with the most recent developments and activities at Taros by reading our press releases.
As a leading contract research organization in discovery chemistry and custom synthesis, Taros provides comprehensive solutions to meet our clients’ needs from diverse branches and applications
Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations, despite challenges, bridging very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project, starting from the development of synthetic routes to…